Prediction of Incomplete Response of Primary Tumour Based on Clinical and Radiomics Features in Inoperable Head and Neck Cancers after Definitive Treatment

Radical treatment of patients diagnosed with inoperable and locally advanced head and neck cancers (LAHNC) is still a challenge for clinicians. Prediction of incomplete response (IR) of primary tumour would be of value to the treatment optimization for patients with LAHNC. Aim of this study was to d...

Full description

Saved in:
Bibliographic Details
Published in:Journal of personalized medicine 2022-06, Vol.12 (7), p.1092
Main Authors: Kaźmierska, Joanna, Kaźmierski, Michał R., Bajon, Tomasz, Winiecki, Tomasz, Bandurska-Luque, Anna, Ryczkowski, Adam, Piotrowski, Tomasz, Bąk, Bartosz, Żmijewska-Tomczak, Małgorzata
Format: Article
Language:English
Subjects:
Biopsy
Cancer therapies
Chemotherapy
Clinical medicine
Computed tomography
Head & neck cancer
Localization
Medical prognosis
Medical research
Oral cavity
Patients
Precision medicine
Prediction models
Radiation therapy
Radiomics
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Radical treatment of patients diagnosed with inoperable and locally advanced head and neck cancers (LAHNC) is still a challenge for clinicians. Prediction of incomplete response (IR) of primary tumour would be of value to the treatment optimization for patients with LAHNC. Aim of this study was to develop and evaluate models based on clinical and radiomics features for prediction of IR in patients diagnosed with LAHNC and treated with definitive chemoradiation or radiotherapy. Clinical and imaging data of 290 patients were included into this retrospective study. Clinical model was built based on tumour and patient related features. Radiomics features were extracted based on imaging data, consisting of contrast- and non-contrast-enhanced pre-treatment CT images, obtained in process of diagnosis and radiotherapy planning. Performance of clinical and combined models were evaluated with area under the ROC curve (AUROC). Classification performance was evaluated using 5-fold cross validation. Model based on selected clinical features including ECOG performance, tumour stage T3/4, primary site: oral cavity and tumour volume were significantly predictive for IR, with AUROC of 0.78. Combining clinical and radiomics features did not improve model’s performance, achieving AUROC 0.77 and 0.68 for non-contrast enhanced and contrast-enhanced images respectively. The model based on clinical features showed good performance in IR prediction. Combined model performance suggests that real-world imaging data might not yet be ready for use in predictive models.
ISSN:2075-4426
2075-4426
DOI:10.3390/jpm12071092